Avoid valproate in patients with IARS2 mutations

Josef Finsterer; Sinda Zarrouk-Mahjoub

doi:10.1016/j.braindev.2018.07.019

Journal articles

Avoid valproate in patients with IARS2 mutations

Josef Finsterer ^{1, *} Sinda Zarrouk-Mahjoub ²

* Corresponding author

1 Krankenanstalt Rudolfstiftung

2 LR11IPT05 - Laboratoire de Génomique Biomédicale et Oncogénétique - Biomedical Genomics and Oncogenetics Laboratory

Abstract : Letter to the Editor

Keywords : Leigh syndromes Toxicity IARS2 mitochondrial Epilepsy

Document type :

Journal articles

Domain :

Life Sciences [q-bio] / Human health and pathology

Complete list of metadata

https://hal-riip.archives-ouvertes.fr/pasteur-02002174
Contributor : Abdelhakim Ben Hassine Connect in order to contact the contributor
Submitted on : Thursday, January 31, 2019 - 3:19:15 PM
Last modification on : Wednesday, October 28, 2020 - 9:52:05 AM

Avoid valproate in patients with IARS2 mutations

Identifiers

Collections

Citation

Export

Metrics

Avoid valproate in patients with IARS2 mutations

Identifiers

Collections

Citation

Export

Share

Metrics